ERBB2 and breast neoplasm: In HER2 gastric carcinomas, alike HER2 breast tumors [12], GSDMB over-expression associates with relapse (p = 0.060, Supplementary Table 2), thus supporting the relationship between high levels of GSDMB and poor prognosis in gastric tumors.